Skip to main content
. 2017 Jun 7;28(10):3089–3099. doi: 10.1681/ASN.2017010108

Table 3.

Outcomes

Outcomes All Patients, n=112 Minimal or Negative Hematuria during Follow-Up, n=66 Persistent Hematuria during Follow-Up, n=46 P Value
ESRD, no. (%) 21 (17.2) 7 (10.6) 14 (30.4) 0.01
50% Reduction in renal function, no. (%) 27 (22.1) 10 (15.2) 17 (37) 0.01
Rate of renal function decline, ml/min per 1.73 m2 per yr −2.34±5 −1.54±3.92 −3.34±6.12 0.06